Halo Labs (WSLFF) Stock Price, News & Analysis

Company Overview

Halo Labs, trading on the OTCMKTS as WSLFF, is a U.S.-based company specializing in the extraction, formulation and manufacturing of cannabis-derived products. Leveraging proprietary processes and state-of-the-art equipment, the company produces high-purity distillates, isolates and formulations tailored for vape cartridges, edibles and topicals. Halo Labs offers extraction services including hydrocarbon and CO₂ methods, decarboxylation and post-processing, serving both its own branded product lines and third-party partners.

In addition to its in-house brands, Halo Labs provides turnkey white-label and tolling solutions, supporting licensed cannabis operators with product development, formulation optimization and regulatory compliance. The company operates extraction and manufacturing facilities in key U.S. markets, including California, Nevada and Maryland, enabling it to supply regional dispensaries and distribution networks with bulk cannabinoids and finished products.

Founded in 2018, Halo Labs has focused on scaling its extraction capacity and expanding its service offerings to meet growing demand for consistent, high-quality cannabis derivatives. Its vertically integrated approach—from raw biomass intake to finished-goods packaging—allows for rigorous quality control and cost efficiencies. The firm’s research and development efforts target cannabinoid isolation, terpene retention and novel delivery systems to address evolving consumer preferences.

Halo Labs is led by CEO Steve Allan, whose background in operational management and product development drives the company’s growth strategy. Under his direction, the organization continues to invest in advanced processing capabilities and strategic partnerships, positioning Halo Labs as a key supplier in the rapidly developing legal cannabis industry.

Key Stats

• Today's Range: $0.08 to $0.09
• 50-Day Range: $0.08 to $0.10
• 52-Week Range: $0.05 to $2.44
• Volume: 32,749 shs
• Average Volume: 44,446 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:WSLFF
• CIK: N/A
• Web: www.westleaf.com
• Phone: 403 801 7612
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A